Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age

scientific article published on 01 May 2005

Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2005.01.092
P698PubMed publication ID15837229

P2093author name stringDonald W Spady
Susette Audet
Henry F Pabst
Judith A Beeler
Margaret P Krezolek
Mary M Carson
P2860cites workMeasles antibody: reevaluation of protective titersQ34251667
Regulation of the immune response by antigenQ34308004
Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of lifeQ35172905
Epidemiology of measles in the United States in 1989 and 1990Q35411849
The effect of dose and strain of live attenuated measles vaccines on serological responses in young infantsQ38958657
Ontogeny of the immune response as a basis of childhood diseaseQ40258535
Identification of an association between HLA class II alleles and low antibody levels after measles immunizationQ40680106
Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunityQ40787251
The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.Q41981237
Planning for epidemics--the lessons of SARS.Q43218060
A comparison of alternate immunization regimes for measles in vaccinated populationsQ43590419
Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infantsQ43867069
Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 monthsQ44014938
Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccineQ44911574
Role of virus strain dm conventional and enhanced measles plaque neutralization testQ45791537
Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United StatesQ46961499
Protective titres of measles neutralising antibody.Q50667308
Evaluation of an early two-dose measles vaccination schedule.Q50688006
Differential CD4 T cell activation in measles.Q52514081
Increased susceptibility to measles in infants in the United StatesQ64131284
Reduced measles immunity in infants in a well-vaccinated populationQ68049340
The role of secondary vaccine failures in measles outbreaksQ69972932
Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody responseQ70333506
Secondary immune responses in parents of children with recent measlesQ71778200
Measles vaccination of infants in a well-vaccinated populationQ72154217
P433issue25
P921main subjectmeaslesQ79793
measles vaccineQ6804161
P1104number of pages9
P304page(s)3247-3255
P577publication date2005-05-01
P1433published inVaccineQ7907941
P1476titleFollow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age
P478volume23

Reverse relations

cites work (P2860)
Q36746934Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children
Q64125821Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age
Q90237843Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
Q54421066Subacute sclerosing panencephalitis should be eliminated by measles vaccination.
Q39009658Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules
Q38048555The status of live viral vaccination in early life

Search more.